Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Exosomes show promise for diagnosing and treating skin conditions and hair loss.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

TNF-alpha inhibitors can cause various immune-related skin issues.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Stress may trigger hair loss by affecting immune protection in hair follicles.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Finasteride's effectiveness for frontal fibrosing alopecia is uncertain.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Focal alopecia in dogs has many causes and requires various tests for accurate diagnosis and treatment.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

New genetic discoveries may lead to better treatments for alopecia areata.

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.